Literature DB >> 120419

Gallium-68 labeling of albumin and albumin microspheres.

S J Wagner, M J Welch.   

Abstract

Because of the high stability constant of gallium transferrin, the formation of a protein that will be stable in vivo and labeled with gallium-68 (a positron emitter) requires preliminary coupling of a strong chelating group to the protein. In the present study, we have used a reaction developed by Krejcarek and Tucker, in which DTPA is coupled to proteins by the formation of an amide bond. Using human serum albumin (HSA) as a model, we have studied the efficiency of the reaction of HSA with the mixed acid anhydride of the quarternary triethyl ammonium salt of DTPA and butyl formate, as a function of the ratio of albumin to DTPA. After purification of the DTPA-labeled HSA, it is possible to prepare Ga-68-labeled albumin in high yield by chelation of the Ga-68 with the DTPA-labeled protein. In vitro and in vivo stability studies showed that the labeled protein was stable over a period of several hours. The same type of bifunctional chelate has been used to attach Ga-68 to HSA microspheres.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120419

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  What can gallium-68 PET add to receptor and molecular imaging?

Authors:  Adil Al-Nahhas; Zarni Win; Teresa Szyszko; Aviral Singh; Sameer Khan; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12       Impact factor: 9.236

2.  A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer.

Authors:  Carla J Mathias; Mark A Green
Journal:  Appl Radiat Isot       Date:  2008-06-11       Impact factor: 1.513

3.  PET aerosol lung scintigraphy using Galligas.

Authors:  Jörg Kotzerke; Michael Andreeff; Gerd Wunderlich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

4.  Multimodality imaging of blood-brain barrier impairment during epileptogenesis.

Authors:  Heike Breuer; Martin Meier; Sophie Schneefeld; Wolfgang Härtig; Alexander Wittneben; Martin Märkel; Tobias L Ross; Frank M Bengel; Marion Bankstahl; Jens P Bankstahl
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  Dalton Trans       Date:  2011-03-25       Impact factor: 4.390

6.  Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands.

Authors:  David J Berry; Yongmin Ma; James R Ballinger; Richard Tavaré; Alexander Koers; Kavitha Sunassee; Tao Zhou; Saima Nawaz; Gregory E D Mullen; Robert C Hider; Philip J Blower
Journal:  Chem Commun (Camb)       Date:  2011-05-27       Impact factor: 6.222

7.  Cyclotron production of carrier-free 66Ga as a positron emitting label of albumin colloids for clinical use.

Authors:  P Goethals; M Coene; G Slegers; P Agon; J Deman; K Schelstraete
Journal:  Eur J Nucl Med       Date:  1988

Review 8.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513

9.  In vitro and in vivo effects of diethylene triamine penta-acetic acid on the distribution of indium-111 monoclonal antibody metabolism.

Authors:  Y Kimura; T Fujii; K Ochi; A Akamune; K Hamamoto
Journal:  Eur J Nucl Med       Date:  1992

10.  Improved tumour localisation using indium-111 labelled antibodies.

Authors:  D S Fairweather; A R Bradwell; P W Dykes; A T Vaughan; S F Watson-James; S Chandler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.